source
- Detalimogene Voraplasmid Achieves 54% Complete Response in BCG-Unresponsive Bladder CancerA clinical study of detalimogene voraplasmid reported a 54% complete response rate in patients with heavily pretreated, BCG‑unresponsive non‑muscle‑invasive bladder cancer that also had carcinoma i…
- Supreme Court blocks lower court ruling, keeps mail-order access to abortion pill mifepristoneThe Supreme Court issued an indefinite stay that preserves mail-order access to the abortion medication mifepristone. The order maintains the ability for providers to prescribe the drug through pha…